Zobrazeno 61 - 70
of 236
pro vyhledávání: '"TAKAHIKO NAGAMINE"'
Publikováno v:
Innov Clin Neurosci
Autor:
Takahiko Nagamine
Publikováno v:
Cjem
Autor:
Takahiko Nagamine
Publikováno v:
The Journal of Emergency Medicine. 61:207-208
Autor:
Takahiko Nagamine
Publikováno v:
Geriatrics & Gerontology International. 21:745-746
Autor:
Shingo Kanemura, Takahiko Nagamine, Yasushi Ishihama, Seiji Torii, Kenji Inaba, Robert B. Mackin, Seiichiro Tada, Takayuki Anazawa, Hajime Umezawa, Masaki Okumura, Koshi Imami, Tokiro Ishikawa, Kazutoshi Mori, Misaki Kinoshita, Kenta Inoguchi, Satoshi Ninagawa
Publikováno v:
eLife
eLife, Vol 9 (2020)
eLife, Vol 9 (2020)
Second-generation antipsychotics are widely used to medicate patients with schizophrenia, but may cause metabolic side effects such as diabetes, which has been considered to result from obesity-associated insulin resistance. Olanzapine is particularl
Autor:
Yasushi Ishihama, Shingo Kanemura, Misaki Kinoshita, Masaki Okumura, Satoshi Ninagawa, Seiichiro Tada, Kenta Inoguchi, Takahiko Nagamine, Tokiro Ishikawa, Takayuki Anazawa, Hajime Umezawa, Robert B. Mackin, Kenji Inaba, Koshi Imami, Kazutoshi Mori, Seiji Torii
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6326fb6d517879d70e5e135008938f3f
https://doi.org/10.7554/elife.60970.sa2
https://doi.org/10.7554/elife.60970.sa2
Autor:
TAKAHIKO NAGAMINE, TAKESHI WATANABE
Publikováno v:
Innovations in Clinical Neuroscience; Jan-Mar2024, Vol. 21 Issue 1-3, p8-9, 2p
Autor:
Takahiko Nagamine
Publikováno v:
Psychiatria Danubina; 2024, Vol. 36 Issue 1, p151-152, 2p
Autor:
Takahiko Nagamine
Publikováno v:
International Medical Journal; Dec2023, Vol. 30 Issue 6, p331-332, 2p